NCT02233972View on ClinicalTrials.gov

A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics Of Midazolam

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 31, 2014

Conditions
Pharmacokinetics
Interventions
DRUG

Midazolam

DRUG

Ginkgolides Meglumine Injection

DRUG

placebo

Trial Locations (1)

210029

The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing

Sponsors
All Listed Sponsors
lead

Jiangsu Kanion Pharmaceutical Co., Ltd

INDUSTRY

NCT02233972 - A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics Of Midazolam | Biotech Hunter | Biotech Hunter